Last reviewed · How we verify

NCT05207852

Clinical Pharmacology of Dexamethasone in Pregnant Women With Preterm Labor

Recruiting now Last updated 26 January 2022
What this trial tests

trial in Respiratory Distress Syndrome of Newborn in 288 participants. Currently enrolling.

Timeline
1 December 2021
Primary endpoint
31 December 2025
31 December 2027

Quick facts

Lead sponsorDongyang Liu
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment288
Start date1 December 2021
Primary completion31 December 2025
Estimated completion31 December 2027
Sites1 location across China

Conditions studied

Sponsor

Dongyang Liu

Who can join

Adults 20 to 40, female only, with Respiratory Distress Syndrome of Newborn or Threatened Premature Labor, Antepartum. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study through to the pregnant woman blood concentrations of dexamethasone therapy after research, explore the pharmacokinetic data of dexamethasone in pregnant women, Chinese pregnant women dexamethasone pharmacokinetic model, provide a reference for the clinical use of dexamethasone dose, through the biomarkers of dexamethasone to promote fetal lung maturity and other metabolomics, It provides the basis for the effectiveness and safety study of dexamethasone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Dongyang Liu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05207852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing